SARGENT INVESTMENT GROUP, LLC – Bristol-Myers Squibb Company Transaction History
SARGENT INVESTMENT GROUP, LLC portfolio value:
$655,000
portfolio value
SARGENT INVESTMENT GROUP, LLC quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.56% | -446 shares | -98K | $71.09 | 9.32K |
| Q2 2022 | share | Decrease | -8.69% | -930 shares | -29K | $77 | 9.77K |
| Q1 2022 | share | Increase | +1.10% | 116 shares | 122K | $73.03 | 10.70K |
| Q4 2021 | share | Decrease | -3.29% | -360 shares | 12K | $62.52 | 10.58K |
| Q3 2021 | share | Increase | +3.16% | 335 shares | -61K | $59.17 | 10.94K |
| Q2 2021 | share | Increase | +0.14% | 15 shares | 40K | $65.79 | 10.61K |
| Q1 2021 | share | Increase | +23.51% | 2.01K shares | 137K | $62.15 | 10.59K |
| Q4 2020 | share | Increase | +105.02% | 4.39K shares | 280K | $60.6 | 8.58K |
| Q3 2020 | share | Increase | 0.00% | 4.18K shares | 252K | $58 | 4.18K |